OtherTop Companies
Other

Top Bone Scan Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Other

Published

Feb 2026

Share:

Other

Top Bone Scan Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
1.23 Billion
2026 Forecast (US$)
1.30 Billion
2032 Forecast (US$)
1.83 Billion
CAGR (2025-2032)
5.90%

Summary

The Bone Scan market is in a steady expansion phase, driven by rising cancer incidence, osteoporosis screening, and procedural safety expectations. Leading Bone Scan market companies are consolidating share through integrated imaging platforms, AI-enabled diagnostics, and service contracts. The sector is projected to grow from US$ 1.23 Billion in 2025 to US$ 1.83 Billion by 2032, a 5.90% CAGR.

2025 Revenue of Top Bone Scan Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

The ranking of Bone Scan market companies is based on a composite scoring framework combining quantitative and qualitative indicators. Core criteria include 2025 Bone Scan revenue, multi-year revenue trajectory, and global installed base of nuclear medicine and hybrid imaging systems. We also evaluate technology differentiation in SPECT, SPECT/CT, PET/CT, software, and tracers; portfolio breadth across oncology, orthopedics, and cardiology applications; and depth of service coverage, including uptime guarantees and remote monitoring. Additional weight is assigned to long-term maintenance and managed-service contracts, regulatory approvals, and the scale of R&D investment. Deal momentum is captured through recent project wins, major tenders, and strategic partnerships. Each factor is normalized, scored, and aggregated to produce a final ranking that emphasizes sustainable competitive advantage rather than one-year sales spikes.

Top 10 Companies in Bone Scan

1
GE HealthCare
North America, Europe, Asia Pacific
SPECT and SPECT/CT systems, molecular imaging software, service contracts
Chicago, USA
High-throughput nuclear medicine cameras and integrated workflow solutions for oncology and orthopedics
34.10%
US$ 420.00 Million
Expanded AI-enabled molecular imaging platform, secured multi-year enterprise imaging deals with leading hospital networks
2
Siemens Healthineers
Europe, North America, Middle East
SPECT/CT, PET/CT, advanced reconstruction software, enterprise service
Erlangen, Germany
Premium hybrid imaging systems with strong integration into hospital IT and radiology workflows
29.30%
US$ 360.00 Million
Launched next-generation low-dose SPECT/CT platform and expanded value-based service agreements
3
Philips Healthcare
North America, Europe, Latin America
SPECT, PET/CT, imaging informatics, cloud-based analytics
Best, Netherlands
Patient-centric imaging solutions with strong software and interoperability strengths
17.10%
US$ 210.00 Million
Expanded cloud imaging ecosystem and introduced workflow tools optimized for oncology bone scanning
4
Canon Medical Systems Corporation
Asia Pacific, Europe
SPECT/CT systems, CT platforms used in hybrid imaging
Tochigi, Japan
Hybrid systems optimized for radiation dose reduction and workflow efficiency
5.70%
US$ 70.00 Million
Strengthened molecular imaging portfolio in Japan and selective European markets through distributor alliances
5
Fujifilm Healthcare
Asia Pacific, Latin America
Nuclear medicine cameras, PACS/VNA, diagnostic software
Tokyo, Japan
Integrated imaging IT and mid-range nuclear medicine systems for value-conscious providers
3.70%
US$ 45.00 Million
Leveraged imaging IT footprint to bundle nuclear medicine solutions in growth markets
6
Miltenyi Imaging & Diagnostics
Europe, North America
Specialty nuclear imaging systems and research-grade platforms
Bergisch Gladbach, Germany
Niche high-resolution imaging for research and specialized oncology centers
2.60%
US$ 32.00 Million
Expanded into clinical bone oncology centers with compact SPECT devices
7
Segami Corporation
North America, Middle East
Nuclear medicine software, SPECT reconstruction, workflow tools
Maryland, USA
Vendor-neutral software improving image quality and workflow on installed hardware base
2.00%
US$ 24.00 Million
Rolled out AI-assisted bone SPECT analysis modules and multi-vendor integration packages
8
Mediso Medical Imaging Systems
Europe, Asia Pacific
Clinical and preclinical SPECT/CT systems
Budapest, Hungary
Flexible modular systems serving both clinical and research bone scan needs
1.80%
US$ 22.00 Million
Penetrated emerging markets with mid-cost hybrid systems tailored for bone imaging
9
DDD-Diagnostic A/S
Europe, Middle East
Gamma cameras and SPECT systems
Horsholm, Denmark
Cost-efficient gamma cameras for routine bone scanning procedures
1.50%
US$ 18.00 Million
Refreshed camera portfolio with compact systems for regional hospitals
10
Spectrum Dynamics Medical
North America, Europe
Ultra-high-resolution SPECT and CZT-based systems
Haifa, Israel
Next-generation SPECT technology with high sensitivity and spatial resolution
1.30%
US$ 16.00 Million
Showcased advanced CZT SPECT capabilities for oncology bone imaging in leading centers

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

GE HealthCare

GE HealthCare is a global leader in molecular imaging, offering comprehensive Bone Scan solutions spanning hardware, software, and lifecycle services.

Key Financials: 2025 Bone Scan revenue US$ 420.00 Million; segment CAGR 5.90% aligned with overall market growth.
Flagship Products: Discovery NM/CT 870 Series, Optima NM/CT Series, Xeleris Workflow Suite
2025-2026 Actions: Expanded AI-enabled image reconstruction, secured enterprise fleet upgrades, and deepened service outsourcing partnerships with major health systems.
Three-line SWOT: Strong global installed base and service network; High upfront system pricing versus value competitors; Opportunity—upgrade wave from aging SPECT systems in developed markets.
Notable Customers: Mayo Clinic, Cleveland Clinic, NHS Trusts UK
2

Siemens Healthineers

Siemens Healthineers delivers premium hybrid imaging platforms and integrated IT solutions widely used for oncologic and orthopedic Bone Scan procedures.

Key Financials: 2025 Bone Scan revenue US$ 360.00 Million; operating margin 15.20% for molecular imaging segment.
Flagship Products: Symbia Pro.specta SPECT/CT, Biograph PET/CT, syngo.via Imaging Software
2025-2026 Actions: Introduced low-dose SPECT/CT tailored for bone oncology and expanded value-based managed-service agreements in Europe and North America.
Three-line SWOT: Technologically advanced hybrid systems; Complexity of portfolio may slow configuration decisions; Opportunity—growth in value-based care and comprehensive imaging contracts.
Notable Customers: Charité Berlin, Kaiser Permanente, Apollo Hospitals
3

Philips Healthcare

Philips Healthcare provides integrated imaging and informatics platforms, emphasizing patient comfort and workflow efficiency in Bone Scan imaging.

Key Financials: 2025 Bone Scan revenue US$ 210.00 Million; R&D spend about 9.50% of imaging revenues.
Flagship Products: BrightView SPECT, Vereos PET/CT, IntelliSpace Portal Oncology Suite
2025-2026 Actions: Expanded cloud-based image management, launched oncology-focused workflow enhancements, and intensified cross-selling across diagnostic imaging modalities.
Three-line SWOT: Strong software and interoperability; Smaller nuclear medicine share than top two peers; Opportunity—cloud-native enterprise imaging in large hospital networks.
Notable Customers: Mount Sinai Health System, Grupo Fleury, UPMC
4

Canon Medical Systems Corporation

Canon Medical Systems focuses on dose-efficient hybrid imaging platforms, increasingly adopted for routine and advanced Bone Scan applications.

Key Financials: 2025 Bone Scan revenue US$ 70.00 Million; imaging systems CAGR 6.10% in Asia Pacific.
Flagship Products: Celesteion SPECT/CT, Aquilion CT Series for hybrid imaging, Vitrea Advanced Visualization
2025-2026 Actions: Expanded distributor-led sales in Southeast Asia and introduced workflow tools aimed at orthopedic and oncology imaging centers.
Three-line SWOT: Reputation for image quality and dose reduction; Limited visibility in North American nuclear medicine; Opportunity—government-funded hospital expansion in Asia.
Notable Customers: National Cancer Center Japan, Bumrungrad International Hospital, NHS Scotland
5

Fujifilm Healthcare

Fujifilm Healthcare leverages strong imaging IT assets to provide value-oriented nuclear medicine and Bone Scan solutions in growth markets.

Key Financials: 2025 Bone Scan revenue US$ 45.00 Million; operating margin 12.40% for diagnostic imaging.
Flagship Products: FCR/NM Gamma Camera Line, Synapse PACS, Synapse VNA
2025-2026 Actions: Bundled nuclear medicine cameras with enterprise PACS deals, targeting regional hospitals and private imaging chains in Asia and Latin America.
Three-line SWOT: Robust IT ecosystem and cross-modality presence; Limited premium hybrid imaging portfolio; Opportunity—tiered offerings for mid-income health systems.
Notable Customers: Fortis Healthcare, Rede D'Or São Luiz, Southeast Asian regional hospitals
6

Miltenyi Imaging & Diagnostics

Miltenyi Imaging & Diagnostics addresses specialized oncology and research Bone Scan needs with compact, high-resolution nuclear imaging systems.

Key Financials: 2025 Bone Scan revenue US$ 32.00 Million; R&D intensity about 14.00% of sales.
Flagship Products: MicroSPECT High-Resolution Series, Oncology-Focused SPECT/CT Platforms
2025-2026 Actions: Entered select cancer centers with research-to-clinic upgrade programs and formed collaborations with academic institutions on novel tracers.
Three-line SWOT: Strong niche technology and academic ties; Small global service footprint; Opportunity—expanding role of precision oncology imaging.
Notable Customers: University Hospital Heidelberg, Royal Marsden Hospital, leading European research institutes
7

Segami Corporation

Segami Corporation specializes in nuclear medicine software that enhances image reconstruction and analytics across multi-vendor Bone Scan hardware.

Key Financials: 2025 Bone Scan revenue US$ 24.00 Million; software maintenance revenue share 48.00%.
Flagship Products: OASIS Nuclear Medicine Software Suite, AI Reconstruction and Quantification Modules
2025-2026 Actions: Launched AI-assisted bone SPECT analysis tools, strengthened integration partnerships with OEMs and hospital IT vendors.
Three-line SWOT: Vendor-neutral positioning and deep nuclear software expertise; Dependence on OEM ecosystem; Opportunity—growing demand for AI upgrades on existing scanners.
Notable Customers: HCA Healthcare, Cleveland Clinic Florida, regional nuclear medicine networks
8

Mediso Medical Imaging Systems

Mediso Medical Imaging Systems delivers flexible SPECT/CT solutions serving both clinical Bone Scan workflows and preclinical research imaging.

Key Financials: 2025 Bone Scan revenue US$ 22.00 Million; revenue CAGR 7.20% in export markets.
Flagship Products: AnyScan SPECT/CT, NanoScan Preclinical Systems
2025-2026 Actions: Penetrated new markets in Eastern Europe and Asia with cost-effective hybrid systems and enhanced local service partnerships.
Three-line SWOT: Versatile modular platforms; Smaller scale versus multinational competitors; Opportunity—emerging-market hospital modernization projects.
Notable Customers: Central European university hospitals, regional oncology centers, preclinical research labs
9

DDD-Diagnostic A/S

DDD-Diagnostic A/S focuses on cost-efficient gamma cameras serving routine Bone Scan needs in regional hospitals and imaging centers.

Key Financials: 2025 Bone Scan revenue US$ 18.00 Million; EBITDA margin 11.80%.
Flagship Products: CorCam Gamma Camera Series, SPECT Camera Platforms
2025-2026 Actions: Refreshed product line with compact, lower-maintenance systems targeting smaller hospitals and private clinics in Europe and the Middle East.
Three-line SWOT: Competitive pricing and compact footprint; Limited advanced software and hybrid options; Opportunity—replacement of aging single-head gamma cameras.
Notable Customers: Nordic regional hospitals, Gulf Cooperation Council hospitals, independent imaging centers
10

Spectrum Dynamics Medical

Spectrum Dynamics Medical pioneers CZT-based SPECT technology delivering ultra-high-resolution Bone Scan capabilities in leading oncology centers.

Key Financials: 2025 Bone Scan revenue US$ 16.00 Million; R&D investment 18.00% of annual revenue.
Flagship Products: VERITON-CT Digital SPECT/CT, CZT-Based SPECT Systems
2025-2026 Actions: Expanded clinical evidence base for bone oncology imaging and pursued strategic placements in flagship academic hospitals.
Three-line SWOT: Cutting-edge CZT detectors and image quality; Premium pricing and limited installed base; Opportunity—demand for high-throughput, high-resolution oncology imaging.
Notable Customers: MD Anderson Cancer Center, leading European comprehensive cancer centers, select U.S. academic hospitals

SWOT Leaders

GE HealthCare

SWOT Snapshot

SWOT
Strengths

Extensive installed base, robust service network, and comprehensive portfolio across SPECT, SPECT/CT, and workflow software.

Weaknesses

High capital cost for flagship platforms and complex enterprise sales cycles in mature markets.

Opportunities

Upgrade cycle from legacy SPECT systems and growing demand for AI-enhanced oncology and osteoporosis imaging.

Threats

Price competition from regional OEMs and hospital capital-spending constraints in certain geographies.

Siemens Healthineers

SWOT Snapshot

SWOT
Strengths

Technologically advanced hybrid systems, strong brand, and deep integration with hospital IT and clinical workflows.

Weaknesses

Premium pricing and configuration complexity can lengthen evaluation and procurement timelines for some customers.

Opportunities

Value-based imaging contracts and managed-service models for large health systems and national tenders.

Threats

Macroeconomic volatility, reimbursement pressure, and competition from alternative imaging modalities in oncology follow-up.

Philips Healthcare

SWOT Snapshot

SWOT
Strengths

Strong informatics capabilities, patient-centric design, and solid cross-modality presence in diagnostic imaging.

Weaknesses

Smaller nuclear medicine footprint versus top two leaders and selective geographic gaps in installations.

Opportunities

Cloud-native enterprise imaging platforms enabling advanced Bone Scan analytics and multi-site workflow optimization.

Threats

Heightened cybersecurity and data-sovereignty requirements and aggressive IT competition from pure-play vendors.

Bone Scan Market Regional Competitive Landscape

North America remains the largest Bone Scan market, underpinned by high cancer prevalence, strong reimbursement, and rapid technology adoption. GE HealthCare, Siemens Healthineers, and Philips Healthcare dominate enterprise deals, while Spectrum Dynamics Medical gains visibility in tertiary oncology centers with advanced CZT SPECT/CT placements across the United States and Canada.

Europe shows balanced demand across Western and Central regions, with strong emphasis on dose optimization and cost-effectiveness. Siemens Healthineers and GE HealthCare lead large public tenders, while Mediso Medical Imaging Systems and DDD-Diagnostic A/S compete on mid-range systems. Increasing focus on value-based procurement drives multi-year service contracts and standardized Bone Scan protocols.

Asia Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, government-funded cancer screening, and rising osteoporosis awareness. Canon Medical Systems Corporation and Fujifilm Healthcare leverage strong local presence, while global Bone Scan market companies pursue partnerships with private hospital chains. Mid-tier SPECT/CT systems and basic gamma cameras see strong volume growth.

In Latin America, market growth centers on Brazil, Mexico, and Colombia, where private diagnostic networks and public hospitals are modernizing imaging fleets. Philips Healthcare and GE HealthCare secure key integrated imaging deals, often bundling bone scanning capabilities. Price sensitivity favors value configurations and refurbished systems, benefiting regional distributors and mid-range OEM offerings.

The Middle East and parts of Africa are emerging hubs for advanced oncology imaging, with flagship cancer centers investing in high-end SPECT/CT and PET/CT platforms. Siemens Healthineers and GE HealthCare lead high-end procurements, while DDD-Diagnostic A/S and Segami Corporation support mid-size hospitals through affordable hardware and software upgrades for Bone Scan procedures.

Across all regions, Bone Scan market companies increasingly compete on lifecycle value rather than hardware alone. Multi-modality integration, AI-driven image analysis, and remote service capabilities shape procurement decisions, while regional players such as Mediso and Spectrum Dynamics Medical exploit niche opportunities in specialized oncology centers and research-driven institutions.

Bone Scan Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

NuBone Analytics
Disruptor
USA

Cloud-native AI platform delivering automated Bone Scan quantification, fracture risk scoring, and multi-vendor integration for hospitals seeking software-led performance gains.

GammaLite Imaging
Disruptor
India

Developing ultra-compact, low-cost gamma cameras tailored for high-throughput Bone Scan screening in secondary-care hospitals and diagnostic chains.

CZTera Medical
Disruptor
Germany

Early-stage OEM using modular CZT detector blocks to retrofit existing SPECT systems, boosting resolution for oncology bone imaging at lower upgrade cost.

ScanCloud Diagnostics
Disruptor
United Kingdom

Provides vendor-agnostic cloud archiving and analytics for Bone Scan data, enabling collaborative reading, benchmarking, and population-level disease trend analysis.

OncoTrace Isotopes
Disruptor
South Korea

Specializes in innovative bone-seeking radiopharmaceuticals aimed at improved lesion detectability and reduced scan times in metastatic bone disease.

VitalDose Robotics
Disruptor
Canada

Designs robotic dose-handling and injection systems that automate Bone Scan radiotracer preparation, improving safety and throughput in busy nuclear medicine departments.

Bone Scan Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Bone Scan market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Bone Scanmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.